SPBP4H10.19c Antibody

What is SPBP4H10.19c and what organism does this antibody target?

SPBP4H10.19c refers to an uncharacterized protein (P4H10.19c) found in Schizosaccharomyces pombe strain 972/24843, commonly known as fission yeast. The antibody against this protein is a rabbit-derived polyclonal IgG that has been purified through antigen-affinity techniques. This antibody specifically recognizes epitopes of the hypothetical protein SPBP4H10.19c in S. pombe . Similar to other research antibodies, such specificity is critical for experimental validity, as seen in studies with other antibodies where proper validation is essential for accurate protein detection .

What are the primary applications for SPBP4H10.19c antibody in research?

The SPBP4H10.19c antibody has been validated for use in ELISA (Enzyme-Linked Immunosorbent Assay) and Western Blot (WB) applications . When designing experiments, researchers should approach application validation methodologically:

• For Western Blot: Following standardized protocols similar to those used for Shb antibody validation, including positive controls from overexpression systems and negative controls from knockdown experiments .

• For ELISA: Establishing proper blocking, antibody dilution, and detection parameters to ensure specificity in complex samples.

How should researchers validate SPBP4H10.19c antibody specificity?

Validation of SPBP4H10.19c antibody should follow established antibody validation workflows. Based on methodologies used for similar antibodies:

• Use known positive controls (such as recombinant SPBP4H10.19c protein)

• Include appropriate negative controls (S. pombe strains with SPBP4H10.19c knocked out/down)

• Perform cross-reactivity testing with related proteins

• Validate across multiple applications to ensure consistent specificity

As demonstrated in Shb antibody research, proper validation requires testing against overexpression systems, endogenous protein, and knockdown controls to confirm specificity of detection .

What experimental controls are necessary when using SPBP4H10.19c antibody?

For rigorous research with SPBP4H10.19c antibody, implement controls that address both technical and biological variability:

This approach parallels methods used in studies of other antibodies, where researchers employed both overexpression systems and gene silencing as controls. For instance, in Shb antibody validation, researchers used a V5-tagged Shb overexpression system as a positive control and siRNA knockdown as a negative control .

How can researchers optimize SPBP4H10.19c antibody for Western blot applications?

Optimization of Western blot protocols for SPBP4H10.19c antibody should consider:

• Sample preparation: Evaluate different lysis buffers to maximize protein extraction from S. pombe cells

• Blocking conditions: Test several blocking agents (BSA, milk, commercial blockers) to minimize background

• Antibody concentration: Perform titration experiments (starting with manufacturer recommendations)

• Incubation parameters: Compare different temperatures and durations

• Detection system selection: Choose between chemiluminescence, fluorescence, or colorimetric detection based on sensitivity requirements

Drawing from experiences with other antibodies, researchers should be aware that an antibody may work effectively in one application but not in others, as observed with Shb antibodies that functioned either in Western blotting or immunoprecipitation but not both .

What approaches can resolve inconsistent results when using SPBP4H10.19c antibody?

When facing inconsistent results:

• Verify antibody quality: Test new lots against previously functional lots

• Evaluate protein expression levels: Determine if the target is expressed at detectable levels

• Modify extraction methods: Try alternative protein extraction protocols for S. pombe

• Adjust experimental conditions: Systematically modify incubation times, temperatures, and buffer compositions

• Consider post-translational modifications: Investigate if protein modifications affect epitope recognition

This systematic troubleshooting approach is similar to that employed in TDP-43 antibody development, where researchers carefully characterized antibody performance across multiple experimental systems .

How does SPBP4H10.19c antibody compare with other yeast protein antibodies?

When comparing antibody performance:

• Epitope targeting: SPBP4H10.19c antibody recognizes specific epitopes of the target protein, similar to how other antibodies target specific domains (e.g., N-terminal vs. C-terminal)

• Cross-reactivity profile: Consider potential cross-reactivity with related proteins in S. pombe or other species

• Performance metrics: Compare sensitivity and specificity across applications

• Background signal: Evaluate non-specific binding in different applications

Such comparative analysis resembles approaches used in evaluating multiple Shb antibodies, where researchers systematically compared antibodies targeting different epitopes of the same protein .

What methodologies can quantify SPBP4H10.19c using this antibody?

For quantitative analysis of SPBP4H10.19c:

• Quantitative Western blot: Using standard curves with recombinant protein

• ELISA: Developing sandwich or competitive ELISA protocols

• Immunoassay platforms: Adapting protocols similar to the Meso Scale Discovery (MSD) immunoassay used for TDP-43 quantification

When developing quantitative assays, researchers should validate linearity, dynamic range, reproducibility, and limits of detection and quantification, following principles applied in other antibody-based quantification systems.

What are best practices for designing experiments with SPBP4H10.19c antibody?

Effective experimental design includes:

This approach aligns with methodological rigor demonstrated in studies like the SC27 antibody characterization, where multiple validation steps confirmed antibody performance .

How can researchers troubleshoot cross-reactivity issues with SPBP4H10.19c antibody?

To address potential cross-reactivity:

• Perform epitope mapping to identify specific binding regions

• Test against closely related proteins in S. pombe

• Optimize blocking conditions to reduce non-specific binding

• Consider absorption approaches with non-target proteins

• Validate findings with orthogonal techniques (mass spectrometry, genetic approaches)

This methodical approach parallels strategies used in antibody validation for other targets, where researchers carefully assessed specificity through multiple complementary techniques .

How can SPBP4H10.19c antibody be adapted for immunohistochemistry applications?

While currently validated for ELISA and Western blot, adaptation for immunohistochemistry would require:

• Fixation optimization: Test multiple fixatives (paraformaldehyde, methanol, etc.)

• Antigen retrieval: Evaluate different retrieval methods (heat-induced, enzymatic)

• Signal amplification: Consider tyramide signal amplification or other enhancement methods

• Counterstaining protocols: Develop appropriate nuclear and contextual staining

• Rigorous validation: Include known positive and negative tissue controls

This development process would follow principles similar to those used for TDP-43 antibodies, which were systematically validated for immunohistochemistry applications in patient samples and animal models .

What approaches can characterize post-translational modifications of SPBP4H10.19c?

To investigate post-translational modifications:

• Use modification-specific antibodies in combination with SPBP4H10.19c antibody

• Employ enzymatic treatments (phosphatases, deglycosylases) before antibody detection

• Develop two-dimensional Western blot protocols to separate based on charge and mass

• Implement mass spectrometry following immunoprecipitation

• Correlate findings with functional studies of the protein

This multifaceted approach draws on principles established in studies of phosphorylated TDP-43, where researchers developed specific antibodies against pathologically phosphorylated forms of the protein .